Dr. Russell Portenoy spent decades of his career touting the benefits of powerful prescription painkillers. Now, Portenoy will testify that companies “overstated the benefits of chronic-opioid therapy" and “understated the risks of opioids, particularly the risk of abuse, addiction and overdose," according to a federal-court filing. In other news on the drug crisis: foster care and the epidemic, Purdue Pharma's connection to Tufts Medical School, addiction treatment, and more.
from Kaiser Health News http://bit.ly/2UHor9J
Rose
0 comments:
Post a Comment